Top Five Trends in Cannabis

Delivery

This report comes in PPT.

Key findings

Regulatory ebbs and flows

Cannabis regulatory developments are often hard to predict. This is likely to continue to be the case in the forecast period, especially as geopolitical and socioeconomic conflicts and challenges intensify. In this context, and considering the complexities that characterise the cannabis industry, governments are unlikely to see cannabis legalisation as a top priority.

Adult-use legacy and cross-category interpositions

Although the opening of the cannabis industry has been occurring across the medical, CBD & other non-intoxicating cannabinoids, and adult-use categories, the latter is usually the most influential category in terms of revenue generation and impact on general cannabis-related legislative developments.

Continuous rise of intoxicating hemp-derived products

Hemp-derived intoxicating products are still proliferating, and the consequences are manifold. While it has been enhancing the competition with the legal adult-use category and increasing the chances of cannabis scrutiny from governmental bodies, health authorities and consumers, it has also been opening revenue opportunities in markets in which HDIC products are regulated.

Increasingly tailored product innovation

Cannabis product innovation has been touching on a range of features and functionalities, making them more appealing to a wider breadth of consumers and consequently increasing the “democratisation” and “normalisation” of cannabis.

Corporate challenges in uncertain periods

The last couple of years have been challenging for some cannabis companies, most notably in mature markets such as the US and Canada. Unclear legislative frameworks, high tax burdens, oversupply issues, price decreases, low profitability and an uncertain macroeconomic scenario are among the difficulties that cannabis players have had to confront.